A novel testosterone 2% gel for the treatment of hypogonadal males.

@article{Dobs2012ANT,
  title={A novel testosterone 2% gel for the treatment of hypogonadal males.},
  author={Adrian Dobs and John W McGettigan and Paul Norwood and Julian Howell and Elizabeth Waldie and Yusong Chen},
  journal={Journal of andrology},
  year={2012},
  volume={33 4},
  pages={601-7}
}
Testosterone replacement therapy (TRT) can improve the symptoms, signs, and well being of hypogonadal men by restoring serum testosterone concentrations to physiologic levels. This multicenter, open-label noncomparative trial of men with hypogonadism evaluated the pharmacokinetic profile and safety of a novel testosterone 2% gel (Fortesta™ Gel), administered once daily to the front and inner thighs at starting doses of 40 mg/d. The metered-dose delivery system allowed dose adjustments in 10-mg… CONTINUE READING